Middle East Respiratory Syndrome

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works

A promoter-level mammalian expression atlas

The FANTOM Consortium and the RIKEN PMI and CLST (DGT) (2014) · Nature · doi:10.1038/nature13182 · Cited by 1,982 · see citing works

Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group

de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01244-13 · Cited by 1,238 · see citing works

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P. R., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K., Convalescent Plasma Study Group, Nguyen‐Van‐Tam, J. S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 985 · see citing works

Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans

van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 911 · see citing works

Evidence for Camel-to-Human Transmission of MERS Coronavirus

Azhar, E. I., El-Kafrawy, S. A., Farraj, S. A., Hassan, A. M., Al-Saeed, M. S., Hashem, A. M., & Madani, T. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401505 · Cited by 907 · see citing works

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

Millet, J. K., & Whittaker, G. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407087111 · Cited by 698 · see citing works

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

Chan, J. F., Yao, Y., Yeung, M. L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yü, P., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 607 · see citing works

Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection

Arabi, Y. M., Arifi, A. A., Balkhy, H. H., Najm, H. K., Al‐Dawood, A., Ghabashi, A., Hawa, H., Alothman, A. F., Al-Khaldi, A., & Raiy, B. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2486 · Cited by 573 · see citing works

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

Corman, V. M., Eckerle, I., Bleicker, T., Zaki, A. M., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T. M., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.39.20285-en · Cited by 560 · see citing works

Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections

Memish, Z. A., Zumla, A. I., Alhakeem, R. F., Al-Rabeeah, A. A., & Stephens, G. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303729 · Cited by 493 · see citing works

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Omrani, A. S., Saad, M. M., Baig, K. M., Bahloul, A., Abdul-Matin, M., Aidaroos, A. Y. A., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 493 · see citing works

2014 MERS-CoV Outbreak in Jeddah — A Link to Health Care Facilities

Oboho, I., Tomczyk, S. M., Alasmari, A. M., Banjar, A., Al-Mugti, H. S., Aloraini, M. S., Alkhaldi, K. Z., Almohammadi, E. L., Alraddadi, B. M., Gerber, S. I., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408636 · Cited by 475 · see citing works

Rapid generation of a mouse model for Middle East respiratory syndrome

Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S., Fett, C., Zhao, J., Gale, M., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 452 · see citing works

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques

Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445 · see citing works

Accessory proteins of SARS-CoV and other coronaviruses

Liu, D. X., Fung, T. S., Chong, K. K.-L., Shukla, A., & Hilgenfeld, R. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.06.013 · Cited by 432 · see citing works

Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics

Smith, E. C., Blanc, H., Vignuzzi, M., & Denison, M. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003565 · Cited by 428 · see citing works

Transmission of MERS-Coronavirus in Household Contacts

Drosten, C., Meyer, B., Müller, M. A., Corman, V. M., Almasri, M. M., Hossain, R., Madani, H. H., Sieberg, A., Bosch, B., Lattwein, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405858 · Cited by 393 · see citing works

Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)

Arabi, Y. M., Alharthi, A. F., Hussein, J., Bouchama, A., Johani, S. A., Hajeer, A. H., Saeed, B. T., Wahbi, A. M. A., Saedy, A., Aldabbagh, T., et al. (2015) · Infection · doi:10.1007/s15010-015-0720-y · Cited by 389 · see citing works

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

Chan, J. F., Chan, K., Kao, R. Y. T., To, K. K., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385 · see citing works

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

Ng, D. L., Hosani, F. I. A., Keating, M. K., Gerber, S. I., Jones, T. L., Metcalfe, M. G., Tong, S., Tao, Y., Alami, N. N., Haynes, L. M., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.10.024 · Cited by 384 · see citing works

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

Corman, V. M., Albarrak, A. M., Omrani, A. S., Albarrak, M. M., Farah, M. E., Almasri, M. M., Muth, D., Sieberg, A., Meyer, B., Assiri, A. M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ951 · Cited by 374 · see citing works

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

Min, C.-K., Cheon, S., Ha, N., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J., Inn, K., Kim, J. H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 366 · see citing works

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections

Corman, V. M., Müller, M. A., Costabel, U., Timm, J., Binger, T., Meyer, B., Kreher, P., Lattwein, E., Eschbach-Bludau, M., Nitsche, A., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.49.20334-en · Cited by 360 · see citing works

The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies

Gierer, S., Bertram, S., Kaup, F. ‐., Wrensch, F., Heurich, A., Krämer-Kühl, A., Welsch, K., Winkler, M., Meyer, B., Drosten, C., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00128-13 · Cited by 341 · see citing works

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

Müller, M. A., Meyer, B., Corman, V. M., Almasri, M. M., Turkestani, A., Ritz, D., Sieberg, A., Aldabbagh, S., Bosch, B., Lattwein, E., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70090-3 · Cited by 317 · see citing works

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

de Wit, E., Rasmussen, A. L., Falzarano, D., Bushmaker, T., Feldmann, F., Brining, D. L., Fischer, E. R., Martellaro, C., Okumura, A., Chang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310744110 · Cited by 312 · see citing works

State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans

(2013) · PLoS Currents · doi:10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8 · Cited by 309 · see citing works

Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

Alabdallat, M., Payne, D. C., Alqasrawi, S., Rha, B., Tohme, R. A., Abedi, G. R., Nsour, M. A., Iblan, I., Jarour, N., Farag, N. H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu359 · Cited by 308 · see citing works

Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus

Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 297 · see citing works

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus

Agrawal, A. S., Tao, X., Algaissi, A. A., Garron, T. M., Narayanan, K., Peng, B., Couch, R. B., & Tseng, C.-T. K. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1177688 · Cited by 274 · see citing works

The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists

Yang, Y., Zhang, L., Geng, H., Deng, Y. L., Huang, B., Yin, G., Zhao, Z., & Tan, W. (2013) · Protein & Cell · doi:10.1007/s13238-013-3096-8 · Cited by 273 · see citing works

Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014

Alraddadi, B. M., Watson, J. T., Almarashi, A., Abedi, G. R., Turkistani, A., Sadran, M., Housa, A., AlMazroa, M. A., Alraihan, N., Banjar, A., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2201.151340 · Cited by 269 · see citing works

Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?

Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, É., Titécat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 249 · see citing works

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia

Arabi, Y. M., Hajeer, A. H., Luke, T. C., Raviprakash, K. S., Balkhy, H. H., Johani, S. A., Al‐Dawood, A., Al-Qahtani, S. M., Al‐Omari, A., Al-Hameed, F. M., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2209.151164 · Cited by 244 · see citing works

Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards

Kim, S., Chang, S. Y., Sung, M., Park, J. H., Kim, H. B., Lee, H.-Y., Choi, J., Choi, W. S., & Min, J.-Y. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw239 · Cited by 242 · see citing works

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities

Mielech, A. M., Kilianski, A., Báez-Santos, Y. M., Mesecar, A. D., & Baker, S. C. (2013) · Virology · doi:10.1016/j.virol.2013.11.040 · Cited by 232 · see citing works

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

Tang, X.-C., Agnihothram, S. S., Jiao, Y., Stanhope, J., Graham, R. L., Peterson, E. C., Avnir, Y., Tallarico, A. S. C., Sheehan, J., Zhu, Q., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402074111 · Cited by 232 · see citing works

2015 MERS outbreak in Korea: hospital-to-hospital transmission

Ki, M. (2015) · Epidemiology and Health · doi:10.4178/epih/e2015033 · Cited by 229 · see citing works

Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4

van Doremalen, N., Miazgowicz, K. L., Milne-Price, S., Bushmaker, T., Robertson, S. J., Scott, D. P., Kinne, J., McLellan, J. S., Zhu, J., & Munster, V. J. (2014) · Journal of Virology · doi:10.1128/jvi.00676-14 · Cited by 225 · see citing works

Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation

Chan, J. F., Chan, K., Choi, G. K.-Y., To, K. K., Tse, H., Cai, J., Yeung, M. L., Cheng, V. C., Chen, H., Che, X.-Y., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit123 · Cited by 219 · see citing works

Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein

Jiang, L., Wang, N., Zuo, T., Shi, X., Poon, V. K., Wu, Y., Gao, F., Li, D., Wang, R., Guo, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008140 · Cited by 219 · see citing works

Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset

Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A. L., Okumura, A., Peng, X., Thomas, M. J., van Doremalen, N., Haddock, E., Nagy, L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004250 · Cited by 210 · see citing works

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study

Auyeung, T. W., Lee, J. S. W., Lai, W. K., Choi, C. H., Lee, H. K., Lee, J. S., Li, P. C. K., Lok, K. H., Yeung, Y. M., Wong, W. M., et al. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.09.008 · Cited by 208 · see citing works

Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease

Agrawal, A. S., Garron, T. M., Tao, X., Peng, B., Wakamiya, M., Chan, T., Couch, R. B., & Tseng, C.-T. K. (2015) · Journal of Virology · doi:10.1128/jvi.03427-14 · Cited by 208 · see citing works

IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study

Shalhoub, S., Farahat, F. M., Al-Jiffri, A. M. Y., Simhairi, R., Shamma, O., Siddiqi, N., & Mushtaq, A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv085 · Cited by 190 · see citing works

Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea

Bin, S. Y., Heo, J. Y., Song, M., Lee, J., Kim, E.-H., Park, S., Kwon, H.-I., Kim, S., Kim, Y., Si, Y., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ1020 · Cited by 190 · see citing works

An Observational, Laboratory-Based Study of Outbreaks of Middle East Respiratory Syndrome Coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014

Drosten, C., Muth, D., Corman, V. M., Hussain, R., Masri, M. A., Hajomar, W. H., Landt, O., Assiri, A. M., Eckerle, I., Al-Shangiti, A. M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu812 · Cited by 182 · see citing works

Respiratory Tract Samples, Viral Load, and Genome Fraction Yield in Patients With Middle East Respiratory Syndrome

Memish, Z. A., Al‐Tawfiq, J. A., Makhdoom, H. Q., Assiri, A. M., Alhakeem, R. F., Albarrak, A. M., Alsubaie, S., Al-Rabeeah, A. A., Hajomar, W. H., Hussain, R., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu292 · Cited by 181 · see citing works

Middle East Respiratory Syndrome Coronavirus Disease in Children

Memish, Z. A., Al‐Tawfiq, J. A., Assiri, A. M., Alrabiah, F. A., Hajjar, S. A., Albarrak, A. M., Flemban, H., Alhakeem, R. F., Makhdoom, H. Q., Alsubaie, S., et al. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000325 · Cited by 160 · see citing works

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea

Park, W. B., Perera, R. A. P. M., Choe, P. G., Lau, E. H. Y., Choi, S. J., Chun, J. Y., Oh, H. S., Song, K., Bang, J. H., Kim, E. S., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2112.151421 · Cited by 150 · see citing works

Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin

Lokugamage, K. G., Narayanan, K., Nakagawa, K., Terasaki, K., Ramirez, S. I., Tseng, C.-T. K., & Makino, S. (2015) · Journal of Virology · doi:10.1128/jvi.01352-15 · Cited by 145 · see citing works

Pneumonia from Human Coronavirus in a Macaque Model

Munster, V. J., de Wit, E., & Feldmann, H. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1215691 · Cited by 142 · see citing works

Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus

Payne, D. C., Iblan, I., Alqasrawi, S., Nsour, M. A., Rha, B., Tohme, R. A., Abedi, G. R., Farag, N. H., Haddadin, A., Sanhouri, T. A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu068 · Cited by 110 · see citing works

Emerging Human Middle East Respiratory Syndrome Coronavirus Causes Widespread Infection and Alveolar Damage in Human Lungs

Hocke, A. C., Becher, A., Knepper, J., Peter, A., Holland, G., Tönnies, M., Bauer, T. T., Schneider, P., Neudecker, J., Muth, D., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201305-0954le · Cited by 107 · see citing works

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus

Chan, C.-M., Chu, H., Wang, Y., Wong, B. H., Zhao, X., Zhou, J., Yang, D., Leung, S. P., Chan, J. F., Yeung, M. L., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01133-16 · Cited by 93 · see citing works

Open source clinical science for emerging infections

Dunning, J. W., Merson, L., Rohde, G. G. U., Gao, Z., Semple, M. G., Tran, D., Gordon, A. C., Olliaro, P., Khoo, S., Bruzzone, R., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70327-x · Cited by 89 · see citing works

Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications

Memish, Z. A., Assiri, A. M., & Al‐Tawfiq, J. A. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.10.002 · Cited by 79 · see citing works

Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014

Kraaij‐Dirkzwager, M., Timen, A., Dirksen, K., Gelinck, L. B. S., Leyten, E. M. S., Groeneveld, P. H. P., Jansen, C. L., Jonges, M., Raj, V. S., Thurkow, I., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.21.20817 · Cited by 75 · see citing works

Description of a Hospital Outbreak of Middle East Respiratory Syndrome in a Large Tertiary Care Hospital in Saudi Arabia

Balkhy, H. H., Alenazi, T. H., Alshamrani, M. M., Baffoe-Bonnie, H., Arabi, Y. M., Hijazi, R., Al-Abdely, H. M., El‐Saed, A., Johani, S. A., Assiri, A. M., et al. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.132 · Cited by 69 · see citing works

A Case of Long-term Excretion and Subclinical Infection With Middle East Respiratory Syndrome Coronavirus in a Healthcare Worker

Algethamy, M., Corman, V. M., Hussain, R., Al‐Tawfiq, J. A., Drosten, C., & Memish, Z. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1135 · Cited by 62 · see citing works

Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014

Arwady, M. A., Alraddadi, B. M., Basler, C. A., Azhar, E. I., Abuelzein, E. M. E., Sindy, A. I., Sadiq, B. M. B., Althaqafi, A. O., Shabouni, O. I., Banjar, A., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2208.152015 · Cited by 59 · see citing works

Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections

Zumla, A. I., Azhar, E. I., Arabi, Y. M., Alotaibi, B., Rao, M., McCloskey, B., Petersen, E., & Maeurer, M. J. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.09.005 · Cited by 57 · see citing works

Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia

Muth, D., Corman, V. M., Meyer, B., Assiri, A. M., Almasri, M. M., Farah, M. E., Steinhagen, K., Lattwein, E., Al‐Tawfiq, J. A., Albarrak, A. M., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01368-15 · Cited by 53 · see citing works

Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection

Kim, S. Y., Park, S. J., Cho, S. Y., Cha, R., Jee, H., Kim, G., Shin, H., Kim, Y., Jung, Y. M., Yang, J., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2210.160218 · Cited by 49 · see citing works

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease

Johnson, R. F., Via, L. E., Kumar, M. R., Cornish, J. P., Yellayi, S., Huzella, L., Postnikova, E. N., Oberlander, N., Bartos, C., Ork, B. L., et al. (2015) · Virology · doi:10.1016/j.virol.2015.07.013 · Cited by 48 · see citing works

The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy

Kerkhove, M. D. V., Broberg, E., Engelhardt, O. G., Wood, J., & Nicoll, A. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12068 · Cited by 42 · see citing works

Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns

Al‐Tawfiq, J. A., Omrani, A. S., & Memish, Z. A. (2016) · Frontiers of Medicine · doi:10.1007/s11684-016-0446-y · Cited by 22 · see citing works

Evaluation of Patients under Investigation for MERS-CoV Infection, United States, January 2013–October 2014

Schneider, E., Chommanard, C., Rudd, J., Whitaker, B., Lowe, L., & Gerber, S. I. (2015) · Emerging infectious diseases · doi:10.3201/eid2107.141888 · Cited by 12 · see citing works

Corrigendum to “Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015” [Volume 6, Issue 4, August 2015, 269–278]

Prevention, K. C. F. D. C. A. (2016) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2016.03.002 · Cited by 5 · see citing works

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166 · see citing works

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,016 · see citing works

Co-infections in people with COVID-19: a systematic review and meta-analysis.

Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619 · see citing works

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

Du, R.-H., Liang, L.-R., Yang, C.-Q., Wang, W., Cao, T.-Z., Li, M., Guo, G.-Y., Du, J., Zheng, C.-L., Zhu, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00524-2020 · Cited by 1,452 · see citing works

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D. J., MacFadden, D. R., Soucy, J.-P. R., & Daneman, N. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.016 · Cited by 1,587 · see citing works

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Agostini, M. L., Andres, E. L., Sims, A. M., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,418 · see citing works

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

Arabi, Y. M., Mandourah, Y., Al-Hameed, F. M., Sindi, A., Almekhlafi, G. A., Hussein, M. A., Jose, J., Pinto, R. L., Al‐Omari, A., Kharaba, A. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1172oc · Cited by 1,122 · see citing works

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073 · see citing works

Practical recommendations for the management of diabetes in patients with COVID-19

Bornstein, S. R., Rubino, F., Khunti, K. K., Mingrone, G., Hopkins, D., Birkenfeld, A. L., Boehm, B. O., Amiel, S. A., Holt, R. I. G., Skyler, J. S., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30152-2 · Cited by 956 · see citing works

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series StudyPreprint

Mao, L., Wang, M., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., Miao, X., Hu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.02.22.20026500 · Cited by 882 · see citing works

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

McGonagle, D., O’Donnell, J. S., Sharif, Κ., Emery, P., & Bridgewood, C. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30121-1 · Cited by 826 · see citing works

COVID-19 and diabetes: Knowledge in progress

Hussain, A., Bhowmik, B., & Moreira, N. C. D. V. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108142 · Cited by 808 · see citing works

COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives

Sun, J., He, W.-T., Wang, L., Lai, A. C.-K., Ji, X., Zhai, X., Li, G., Suchard, M. A., Tian, J., Zhou, J., et al. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.02.008 · Cited by 682 · see citing works

Pandemics: Risks, Impacts, and Mitigation

Madhav, N. K., Oppenheim, B., Gallivan, M. D., Mulembakani, P. M., Rubin, E. M., & WOLFE, N. D. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0527-1_ch17 · Cited by 637 · see citing works

From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses

Zhu, Z., Lian, X., Su, X., Wu, W., Marraro, G. A., & Zeng, Y. (2020) · Respiratory Research · doi:10.1186/s12931-020-01479-w · Cited by 614 · see citing works

Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks

Ashour, H. M., Elkhatib, W. F., Rahman, M. M., & Elshabrawy, H. A. (2020) · Pathogens · doi:10.3390/pathogens9030186 · Cited by 603 · see citing works

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Pruijssers, A. J. P., George, A. S., Schäfer, A., Leist, S. R., Gralinski, L. E., Dinnon, K. H., Yount, B. L., Agostini, M. L., Stevens, L. J., Chappell, J. D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107940 · Cited by 516 · see citing works

Middle East respiratory syndrome

Memish, Z. A., Perlman, S. M., Kerkhove, M. D. V., & Zumla, A. I. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33221-0 · Cited by 481 · see citing works

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

Baj, J., Karakuła‐Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, R., Forma, A., Karakuła, K. H., Flieger, W., Portincasa, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061753 · Cited by 458 · see citing works

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

Hui, D. S. C., Azhar, E. I., Kim, Y., Memish, Z. A., Oh, M., & Zumla, A. I. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30127-0 · Cited by 449 · see citing works

Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

Flerlage, T., Boyd, D. F., Meliopoulos, V., Thomas, P. G., & Schultz‐Cherry, S. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00542-7 · Cited by 406 · see citing works

Type III interferons disrupt the lung epithelial barrier upon viral recognition

Broggi, A., Ghosh, S., Sposito, B., Spreafico, R., Balzarini, F., Cascio, A. L., Clementi, N., Santis, M. D., Mancini, N., Granucci, F., et al. (2020) · Science · doi:10.1126/science.abc3545 · Cited by 398 · see citing works

Observed and Potential Impacts of the COVID-19 Pandemic on the Environment

Cheval, S., Adamescu, M. C., Georgiadis, T., Herrnegger, M., Piticar, A., & Legates, D. R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17114140 · Cited by 327 · see citing works

Lessons for COVID-19 immunity from other coronavirus infections

Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317 · see citing works

COVID-19 and diabetes: Can DPP4 inhibition play a role?

Iacobellis, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108125 · Cited by 313 · see citing works

Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear

Li, J.-P. O., Lam, D. S. C., Chen, Y., & Ting, D. S. W. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-315994 · Cited by 305 · see citing works

Potential intestinal infection and faecal–oral transmission of SARS-CoV-2

Guo, M., Tao, W., Flavell, R. A., & Zhu, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00416-6 · Cited by 305 · see citing works

The Middle East Respiratory Syndrome (MERS)

Azhar, E. I., Hui, D. S. C., Memish, Z. A., Drosten, C., & Zumla, A. I. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.08.001 · Cited by 285 · see citing works

Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview

Behzad, S., Aghaghazvini, L., Radmard, A. R., & Gholamrezanezhad, A. (2020) · Clinical Imaging · doi:10.1016/j.clinimag.2020.05.013 · Cited by 276 · see citing works

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Landewé, R., Machado, P., Kroon, F. P. B., Bijlsma, J. W. J., Burmester, G. R., Carmona, L., Combe, B. G., Galli, M., Gossec, L., Iagnocco, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217877 · Cited by 262 · see citing works

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

And the MIRACLE trial group, Arabi, Y. M., Alothman, A. F., Balkhy, H. H., Al‐Dawood, A., AlJohani, S. M., Harbi, S. A. A., Kojan, S. M., Jeraisy, M. A., Deeb, A., et al. (2018) · Trials · doi:10.1186/s13063-017-2427-0 · Cited by 252 · see citing works

Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study

Arabi, Y. M., Shalhoub, S., Mandourah, Y., Al-Hameed, F. M., Al‐Omari, A., Qasim, E. A., Jose, J., Alraddadi, B. M., Almotairi, A., Khatib, K. A., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz544 · Cited by 248 · see citing works

The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection

Gallo, O., Locatello, L. G., Mazzoni, A., Novelli, L., & Annunziato, F. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00359-2 · Cited by 246 · see citing works

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

McDonald, I., Murray, S. M., Reynolds, C. J., Altmann, D. M., & Boyton, R. J. (2021) · npj Vaccines · doi:10.1038/s41541-021-00336-1 · Cited by 247 · see citing works

SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes

Li, Y., Renner, D. M., Comar, C. E., Whelan, J. N., Reyes, H. M., Cardenas‐Diaz, F. L., Truitt, R., Tan, L. H., Dong, B., Alysandratos, K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022643118 · Cited by 246 · see citing works

Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review

Renu, K., Prasanna, P. L., & Gopalakrishnan, A. V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117839 · Cited by 244 · see citing works

Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study

Wu, G., Yang, P., Woodruff, H. C., Rao, X., Guiot, J., Frix, A.-N., Moutschen, M. P., Louis, R. E., Li, J., Li, J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01104-2020 · Cited by 243 · see citing works

Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019

Barlow, A., Landolf, K. M., Barlow, B., Yeung, S. Y. A., Heavner, J. J., Claassen, C. W., & Heavner, M. S. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2398 · Cited by 239 · see citing works

Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation

Jin, M., Shiwaku, H., Tanaka, H., Obita, T., Ohuchi, S., Yoshioka, Y., Jin, X., Kondo, K., Fujita, K., Homma, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26851-2 · Cited by 223 · see citing works

The immunology of COVID-19: is immune modulation an option for treatment?

Zhong, J., Tang, J., Ye, C., & Dong, L. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30120-x · Cited by 236 · see citing works

Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review

Ahmed, M. H., & Hassan, A. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00610-8 · Cited by 239 · see citing works

Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights

Divani, A. A., Andalib, S., Napoli, M. D., Lattanzi, S., Hussain, M. S., Biller, J., McCullough, L. D., Azarpazhooh, M. R., Seletska, A., Mayer, S. A., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104941 · Cited by 231 · see citing works

A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage

Cui, Y., Tian, M., Huang, D., Wang, X., Huang, Y., Fan, L., Wang, L., Chen, Y., Liu, W., Zhang, K., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa113 · Cited by 230 · see citing works

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)

Agrati, C., Sacchi, A., Bordoni, V., Cimini, E., Notari, S., Grassi, G., Casetti, R., Tartaglia, E., Lalle, E., D’Abramo, A., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0572-6 · Cited by 229 · see citing works

Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss

Kılıç, O., Kalcioglu, M. T., Çağ, Y., Tüysüz, O., Pektaş, E., Çaşkurlu, H., & Çeti̇n, F. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.023 · Cited by 226 · see citing works

Nosocomial Infection

Kollef, M. H., Torres, A., Shorr, A. F., Martín‐Loeches, I., & Micek, S. T. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004783 · Cited by 225 · see citing works

A new threat from an old enemy: Re‑emergence of coronavirus (Review)

Docea, A. O., Tsatsakis, A. M., Albulescu, D. M., Cristea, O. M., Zlatian, O. M., Vinceti, M., Moschos, S. A., Tsoukalas, D., Γούμενου, Μ., Drakoulis, N., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4555 · Cited by 221 · see citing works

Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysisPreprint

Ma, C., Gu, J., Hou, P., Zhang, L., Bai, Y., Guo, Z., Wu, H. Y., Zhang, B., Li, P., & Zhao, X. (2020) · medRxiv · doi:10.1101/2020.03.17.20037572 · Cited by 218 · see citing works

The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century

da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020) · Archives of Virology · doi:10.1007/s00705-020-04628-0 · Cited by 213 · see citing works

Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea

Oh, M., Park, W. B., Park, S., Choe, P. G., Bang, J. H., Song, K., Kim, E. S., Kim, H. B., & Kim, N. J. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.031 · Cited by 215 · see citing works

Carbon nanotube field-effect transistor (CNT-FET)-based biosensor for rapid detection of SARS-CoV-2 (COVID-19) surface spike protein S1

Zamzami, M. A., Rabbani, G., Ahmad, A., Basalah, A. A., Alsabban, W. H., Ahn, S. N., & Choudhry, H. (2021) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2021.107982 · Cited by 211 · see citing works

Nucleoside analogues for the treatment of coronavirus infections

Pruijssers, A. J., & Denison, M. R. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.04.002 · Cited by 196 · see citing works

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases

Carsetti, R., Zaffina, S., Mortari, E. P., Terreri, S., Corrente, F., Capponi, C., Palomba, P., Mirabella, M., Cascioli, S., Palange, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610300 · Cited by 195 · see citing works

COVID-19 revisiting inflammatory pathways of arthritis

Schett, G., Manger, B., Simon, D., & Caporali, R. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0451-z · Cited by 191 · see citing works

Anam-Net: Anamorphic Depth Embedding-Based Lightweight CNN for Segmentation of Anomalies in COVID-19 Chest CT Images

Paluru, N., Dayal, A., Jenssen, H. B., Sakinis, T., Cenkeramaddi, L. R., Prakash, J., & Yalavarthy, P. K. (2021) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2021.3054746 · Cited by 182 · see citing works

Diabetes and COVID-19: evidence, current status and unanswered research questions

Gupta, R., Hussain, A., & Misra, A. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0652-1 · Cited by 183 · see citing works

Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study

Arabi, Y. M., Al‐Omari, A., Mandourah, Y., Al-Hameed, F. M., Sindi, A., Alraddadi, B. M., Shalhoub, S., Almotairi, A., Khatib, K. A., Abdulmomen, A., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002621 · Cited by 180 · see citing works

COVID-19 y diabetes mellitus: una relación bidireccional

Lima-Martínez, M. M., Boada, C. C., Madera-Silva, M. D., Marín, W., & Contreras, M. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.10.001 · Cited by 172 · see citing works

Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference

Beigel, J. H., Nam, H. H., Adams, P. L., Krafft, A. E., Ince, W. L., El‐Kamary, S. S., & Sims, A. M. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.04.006 · Cited by 168 · see citing works

Virus infection induced pulmonary fibrosis

Huang, W., & Tang, X. X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03159-9 · Cited by 167 · see citing works

Pulmonary infections complicating ARDS

Luyt, C. E., Bouadma, L., Morris, A. C., Dhanani, J., Kollef, M. H., Lipman, J., Martín‐Loeches, I., Nseir, S., Ranzani, O., Roquilly, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06292-z · Cited by 169 · see citing works

Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)

Batawi, S., Tarazan, N., Al-Raddadi, R. M., Qasim, E. A., Sindi, A., Johni, S. A., Al-Hameed, F. M., Arabi, Y. M., Uyeki, T. M., & Alraddadi, B. M. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1165-2 · Cited by 162 · see citing works

Virus tinged? Exploring the facets of virtual reality use in tourism as a result of the COVID-19 pandemic

Șchiopu, A. F., Hornoiu, R. I., Pădurean, A. M., & Nica, A.-M. (2021) · Telematics and Informatics · doi:10.1016/j.tele.2021.101575 · Cited by 166 · see citing works

Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection

Franceschi, A. M., Ahmed, O. A., Giliberto, L., & Castillo, M. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6595 · Cited by 162 · see citing works

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trialPreprint

Bian, H., Zheng, Z., Wei, D., Zhang, Z., Kang, W., Hao, C.-Q., Dong, K., Kang, W., Xia, J., Miao, J., et al. (2020) · medRxiv · doi:10.1101/2020.03.21.20040691 · Cited by 162 · see citing works

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 144 · see citing works

Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview

Behl, T., Rocchetti, G., Chadha, S., Zengin, G., BUNGAU, S. G., Kumar, A., Mehta, V., Uddin, M. S., Khullar, G., Setia, D., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14040381 · Cited by 136 · see citing works

Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic

Poljak, M., Korva, M., Knap, N., Komloš, K. F., Sagadin, M., Uršič, T., Avšič‐Županc, T., & Petrovec, M. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00599-20 · Cited by 133 · see citing works

Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview

Fedele, D., Francesco, A. D., Riso, S., & Collo, A. (2020) · Nutrition · doi:10.1016/j.nut.2020.111016 · Cited by 131 · see citing works

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

and the Saudi Critical Care Trials group, Arabi, Y. M., Asiri, A. Y., Assiri, A. M., Jokhdar, H., Alothman, A. F., Balkhy, H. H., AlJohani, S. M., Harbi, S. A. A., Kojan, S. M., et al. (2020) · Trials · doi:10.1186/s13063-019-3846-x · Cited by 128 · see citing works

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

Laporte, M., Raeymaekers, V., Berwaer, R. V., Vandeput, J., Marchand-Casas, I., Thibaut, H. J., Looveren, D. V., Martens, K., Hoffmann, M., Maes, P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009500 · Cited by 123 · see citing works

Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella

Bradley, B. T., & Bryan, A. B. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.04.006 · Cited by 124 · see citing works

The ocular surface, coronaviruses and COVID‐19

Willcox, M. D. P., Walsh, K., Nichols, J. J., Morgan, P. B., & Jones, L. (2020) · Clinical and Experimental Optometry · doi:10.1111/cxo.13088 · Cited by 119 · see citing works

Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis

Nardacci, R., Colavita, F., Castilletti, C., Lapa, D., Matusali, G., Meschi, S., Nonno, F. D., Colombo, D., Capobianchi, M. R., Zumla, A. I., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03527-9 · Cited by 123 · see citing works

Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome

Alraddadi, B. M., Qushmaq, I. A., Al-Hameed, F. M., Mandourah, Y., Almekhlafi, G. A., Jose, J., Al‐Omari, A., Kharaba, A. M., Almotairi, A., Khatib, K. A., et al. (2019) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12635 · Cited by 121 · see citing works

Pandemics: Risks, Impacts, and Mitigation

Madhav, N. K., Oppenheim, B., Gallivan, M. D., Mulembakani, P. M., Rubin, E. M., & WOLFE, N. D. (2017) · Europe PMC (PubMed Central) · doi:10.1596/978-1-4648-0527-1/pt5.ch17 · Cited by 119 · see citing works

Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study

Beigel, J. H., Voell, J., Kumar, P., Raviprakash, K. S., Wu, H., Jiao, J., Sullivan, E. J., Luke, T. C., & Davey, R. T. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30002-1 · Cited by 115 · see citing works

Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis

Hoque, M. N., Akter, S., Mishu, I. D., Islam, M. R., Rahman, M. S., Akther, M., Islam, I., Hasan, M. M., Rahaman, M. M., Sultana, M., et al. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104941 · Cited by 115 · see citing works

Monocyte activation in systemic Covid-19 infection: Assay and rationale

Martínez, F. O., Combes, T., Orsenigo, F., & Gordon, S. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102964 · Cited by 111 · see citing works

A critical evaluation of glucocorticoids in the management of severe COVID-19

Solinas, C., Perra, L., Aiello, M. M., Migliori, E., & Petrosillo, N. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.012 · Cited by 109 · see citing works

Middle East Respiratory Syndrome

Shalhoub, S., Memish, Z. A., & Arabi, Y. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-54841-0.00004-4 · Cited by 108 · see citing works

The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues

Qiao, J., Li, W., Bao, J., Peng, Q., Wen, D., Wang, J., & Sun, B. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.042 · Cited by 103 · see citing works

Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients

Islam, M. A., Kundu, S., Alam, S. S., Hossan, T., Kamal, M. A., & Hassan, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249788 · Cited by 107 · see citing works

Blocking IL-1 to prevent respiratory failure in COVID-19

van de Veerdonk, F. L., & Netea, M. G. (2020) · Critical Care · doi:10.1186/s13054-020-03166-0 · Cited by 105 · see citing works

The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea

Kim, M. K., Jeon, J., Kim, S.-W., Moon, J. S., Cho, N. H., Han, E., You, J. H., Lee, J. Y., Hyun, M., Park, J. S., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0146 · Cited by 102 · see citing works

A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation

Kang, L., He, G., Sharp, A. K., Wang, X., Brown, A. M., Michalak, P., & Weger‐Lucarelli, J. (2021) · Cell · doi:10.1016/j.cell.2021.07.007 · Cited by 97 · see citing works

Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants

Teruel, N., Mailhot, O., & Najmanovich, R. (2020) · bioRxiv · doi:10.1371/journal.pcbi.1009286 · Cited by 97 · see citing works

The history and epidemiology of Middle East respiratory syndrome corona virus

Al-Osail, A. M., & Alwazzeh, M. J. (2017) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-017-0101-8 · Cited by 104 · see citing works

A Novel Scoring System for Prediction of Disease Severity in COVID-19

Zhang, C., Qin, L., Li, K., Wang, Q. M., Zhao, Y., Xu, B., Liang, L., Dai, Y., Feng, Y., Sun, J., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00318 · Cited by 104 · see citing works

Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)

Kurth, F., Rönnefarth, M., Thibeault, C., Corman, V. M., Müller-Redetzky, H., Mittermaier, M., Ruwwe‐Glösenkamp, C., Heim, K. M., Krannich, A., Zvorc, S., et al. (2020) · Infection · doi:10.1007/s15010-020-01464-x · Cited by 100 · see citing works

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control

Wang, S., Li, W., Wang, Z., Yang, W., Li, E., Xia, X., Yan, F., & Chiu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01917-x · Cited by 117 · see citing works

Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients

Buehler, P. K., Zinkernagel, A. S., Hofmaenner, D. A., Wendel‐Garcia, P. D., Acevedo, C., Gómez-Mejía, A., Shambat, S. M., Andreoni, F., Maibach, M. A., Bartussek, J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100229 · Cited by 103 · see citing works

Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections

Skariyachan, S., Challapilli, S. B., Packirisamy, S., Kumargowda, S. T., & Sridhar, V. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00569 · Cited by 99 · see citing works

Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season

Jiang, C., Yao, X., Zhao, Y., Wu, J., Huang, P., Pan, C., Liu, S., & Pan, C. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.05.005 · Cited by 98 · see citing works

Emergent Large Vessel Occlusion Stroke During New York City's COVID-19 Outbreak: Clinical Characteristics and Paraclinical Findings.

Majidi, S., Fifi, J. T., Ladner, T. R., Lara‐Reyna, J., Yaeger, K., Yim, B., Dangayach, N. S., Oxley, T. J., Shigematsu, T., Kummer, B. R., et al. (2020) · PubMed Central · doi:10.1161/strokeaha.120.030397 · Cited by 96 · see citing works

DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients

Seys, L., Widagdo, W., Verhamme, F. M., KleinJan, A., Janssens, W., Joos, G., Bracke, K. R., Haagmans, B. L., & Brusselle, G. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix741 · Cited by 95 · see citing works

A case-crossover analysis of the impact of weather on primary cases of Middle East respiratory syndrome

Gardner, E. G., Kelton, D. F., Poljak, Z., Kerkhove, M. D. V., von Dobschuetz, S., & Greer, A. L. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3729-5 · Cited by 95 · see citing works

Comparative epidemiology between the 2009 H1N1 influenza and COVID-19 pandemics

da Costa, V. G., Saivish, M. V., Santos, D. E. R., Silva, R. F. D. L., & Moreli, M. L. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.09.023 · Cited by 95 · see citing works

Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity

Channappanavar, R., & Perlman, S. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci144115 · Cited by 92 · see citing works

Editorial Commentary: Critical Contribution of Laboratories to Outbreak Response Support for Middle East Respiratory Syndrome Coronavirus

Leitmeyer, K. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu815 · Cited by 2 · see citing works

Middle east respiratory syndrome coronavirus (MERS-CoV): An underestimated betacoronavirus with pandemic potential

Asokan, S., Isiaka, I. D., Jacob, T., Vijayan, S., & Rajeswary, D. (2026) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2026.117367 · Cited by 6 · see citing works

Global Burden and Pathogenesis of Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Epidemiological and Preventive Perspectives

Iheukwumere, I. H., Iheukwumere, C. M., Unaeze, B. C., Ike, V. E., Nnadozie, H. C., & Onyema, S. O. (2025) · IPS Journal of Applied Microbiology and Biotechnology · doi:10.54117/ijamb.v4i4.92 · Cited by 1 · see citing works

Review on Middle East Respiratory Syndrome

Dires, B., & Dawo, F. (2015) · OALib · doi:10.4236/oalib.1101749 · Cited by 1 · see citing works

Middle East Respiratory Syndrome (MERS): The Emerging Zoonoses

Wani, N., Munshi, Z. H., & Ganai, A. W. (2015) · Asian Journal of Animal and Veterinary Advances · doi:10.3923/ajava.2015.843.851